
CIK 0001388658
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 37 | Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Open-market sale | SELL | $884K 7,093 sh | Aug 11, 2026 traded Aug 10, 2026 | |
Patterson ChadCHIEF COMM & PRODUCT OFFICER |
Grant or award |
| A |
| — 13.6K sh |
| Aug 11, 2026 traded Aug 7, 2026 |
| 41 | Shrishrimal SumiEVP, Chief Risk Officer | Open-market sale | SELL | $670K 5,372 sh | Aug 11, 2026 traded Aug 10, 2026 |
| 41 | Patterson ChadCHIEF COMM & PRODUCT OFFICER | Open-market sale | SELL | $884K 7,093 sh | Aug 11, 2026 traded Aug 10, 2026 |
| 13 | Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Grant or award | A | — 13.6K sh | Aug 11, 2026 traded Aug 7, 2026 |
| 17 | Shrishrimal SumiEVP, Chief Risk Officer | Grant or award | A | — 9,706 sh | Aug 11, 2026 traded Aug 7, 2026 |
| 28 | Freeman Sean ClintonEVP, Strategy & Corp Devt | Open-market sale | SELL | $114K 918 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 9 | Patterson ChadCHIEF COMM & PRODUCT OFFICER | Grant or award | A | $17K 177 sh | Jun 1, 2026 traded May 29, 2026 |
| 5 | Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Grant or award | A | $13K 137 sh | Jun 1, 2026 traded May 29, 2026 |
| 9 | Freeman Sean ClintonEVP, Strategy & Corp Devt | Grant or award | A | $26K 273 sh | Jun 1, 2026 traded May 29, 2026 |
| 27 | Patten Jason HDirector | Grant or award | A | — 2,218 sh | Mar 19, 2026 traded Mar 12, 2026 |
| 13 | Smith MervinEVP Strategic Business Ops | Grant or award | A | — 6,689 sh | Feb 27, 2026 traded Feb 25, 2026 |
| 21 | Freeman Sean ClintonEVP, Strategy & Corp Devt | Grant or award | A | — 7,525 sh | Feb 27, 2026 traded Feb 25, 2026 |
| 21 | Smith MervinEVP Strategic Business Ops | Grant or award | A | — 9,210 sh | Feb 26, 2026 traded Feb 24, 2026 |
| 37 | Smith MervinEVP Strategic Business Ops | Open-market sale | SELL | $547K 4,041 sh | Feb 26, 2026 traded Feb 25, 2026 |
| 17 | Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Grant or award | A | — 15.1K sh | Feb 26, 2026 traded Feb 24, 2026 |
| 44 | Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Open-market sale | SELL | $1.06M 7,804 sh | Feb 26, 2026 traded Feb 25, 2026 |
| 21 | Rosenbaum Marc WadeChief Accounting Officer | Grant or award | A | — 9,210 sh | Feb 26, 2026 traded Feb 24, 2026 |
| 41 | Rosenbaum Marc WadeChief Accounting Officer | Open-market sale | SELL | $650K 4,797 sh | Feb 26, 2026 traded Feb 25, 2026 |
| 15 | Rosenbaum Marc WadeChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $39K 280 sh | Feb 25, 2026 traded Feb 24, 2026 |
| 18 | Smith MervinEVP Strategic Business Ops | Open-market sale · 10b5-1 plan | SELL | $103K 732 sh | Feb 25, 2026 traded Feb 24, 2026 |
| 9 | Shrishrimal SumiEVP, Chief Risk Officer | Grant or award | A | $8,727 73 sh | Dec 2, 2025 traded Nov 28, 2025 |
| 9 | Rosenbaum Marc WadeChief Accounting Officer | Grant or award | A | $239 2 sh | Dec 2, 2025 traded Nov 28, 2025 |
| 9 | Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH | Grant or award | A | $19K 250 sh | Dec 2, 2025 traded Nov 28, 2025 |